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Aicardi–Goutie`res syndrome (AGS) is an inflammatory encephalopathy caused by defective nucleic acids
metabolism. Over 50% of AGS mutations affect RNase H2 the only enzyme able to remove single ribonucleotide-
monophosphates (rNMPs) embedded in DNA. Ribonucleotide triphosphates (rNTPs) are incorporated into gen-
omic DNA with relatively high frequency during normal replication making DNA more susceptible to strand
breakage and mutations. Here we demonstrate that human cells depleted of RNase H2 show impaired cell
cycle progression associated with chronic activation of post-replication repair (PRR) and genome instability.
We identify a similar phenotype in cells derived from AGS patients, which indeed accumulate rNMPs in genomic
DNA and exhibit markers of constitutive PRR and checkpoint activation. Our data indicate that in human cells
RNase H2 plays a crucial role in correcting rNMPs misincorporation, preventing DNA damage. Such protective
function is compromised in AGS patients and may be linked to unscheduled immune responses. These findings
may be relevant to shed further light on the mechanisms involved in AGS pathogenesis.
INTRODUCTION
Aicardi–Goutie`res syndrome (AGS) is a rare and underdiagnosed
inflammatory encephalopathy with infancy onset and character-
ized by high levels of Type I interferon (IFN) production. AGS
is caused by defective nucleic acids metabolism due to alterations
in different nucleases or nucleotidases (1–4). The majority of
AGS patients carry mutations in one of three genes coding for
RNase H2 subunits (RNASEH2A, RNASEH2B, RNASE2HC,
also classified as AGS4-2-3, respectively).
RNases H are specialized enzymes that process the RNA
moiety in RNA : DNA hybrid molecules. These hybrid struc-
tures represent physiological intermediates produced during
retroviral infection, retroelement mobilization and during
genome replication, through the synthesis of Okazaki fragments
or when a replication fork collides with the transcriptional
machinery (5,6). Two classes of RNases H, with partially over-
lapping substrate specificity, have been characterized (7). RNase
H1 requires a stretch of at least four consecutive ribonucleotide-
monophosphates (rNMPs) to cleave; in mammals RNase H1 is
essential for mitochondrial DNA replication and the function
of the nuclear form is still unclear (8,9). RNase H2 is a trimeric
complex that, besides being able to process long RNA : DNA
hybrid molecules, has the unique property of cleaving single
rNMPs embedded in genomic DNA. A new and potentially rele-
vant substrate for RNase H2 has been recently identified. Indeed,
recent evidence revealed that ribononucleotide triphosphates
(rNTPs) are misincorporated into genomic DNA with high fre-
quency during normal replication (10–12). Due to the reactive
2′ hydroxyl group in the ribose moiety, RNA is 100 000-fold
more susceptible than DNA to spontaneous hydrolysis under
physiological conditions (13). The choice of DNA instead of
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RNA as the information storage molecule is critical for genome
stability. Stable incorporation of rNTPs in DNA needs to be
avoided, as it makes DNA prone to strand breakage and muta-
genesis (14–16). DNA polymerases have evolved active sites
that distinguish between rNTPs and deoxyribonucleotide tripho-
sphates (dNTPs), and select the latter for DNA replication (17).
However, the fidelity of DNA polymerases is challenged by the
high ratio of rNTPs to dNTPs that ranges from 10- to 100-fold in
Saccharomyces cerevisiae (10) and in mammalian cells (18).
Moreover, rNTPs may be added to DNA filaments during
repair of double-strand breaks (DSBs) in G1 (19,20) and frequent
rNTPs incorporation was observed during HIV-1 reverse tran-
scription (21). Altogether, these findings established that incorp-
oration of rNTPs in genomic DNA is the most frequent source of
endogenous DNA modification in replicating cells, and it is well
established that cells have evolved various surveillance mechan-
isms to preserve genome integrity during DNA replication and
facilitate repair (22–24).
Budding yeast cells carrying combined deletions of RNase H1
and RNase H2 genes are viable, although they show evident cell
growth defects due, at least partly, to the accumulation of
genomic rNMPs (25). Conversely, both RNase H1 and RNase
H2 null mice die during embryogenesis, demonstrating the
essential function of these enzymes in mouse development
(9,11,12). Concordantly, only hypomorphic RNase H2 muta-
tions have been reported in AGS patients, suggesting an essential
role for RNase H2 (2,26–29). In vertebrates, studies investigat-
ing the effect of RNase H2 dysfunction have been carried out in
mouse embryonic fibroblasts (11,12). Studies in human cells,
modulating the expression of the RNase H2 genes by RNA inter-
ference and exploiting patients-derived cell lines, would be
useful to identify the molecular mechanisms perturbed by
RNase H2 defects in AGS.
To characterize the effects of RNAse H2 dysfunction, we used
both ∗∗∗AGS2, AGS4-mutated cells and lentiviral vectors carry-
ing specific shRNA sequences to induce stable RNase H2 knock-
down in human cell lines. Here, we report that depletion of
RNase H2 in culture cells or AGS hypomorphic mutations in
patients-derived lymphoblastoid cells lead to the accumulation
of genomic rNMPs, causing endogenous replication stress, as
evidenced by impaired cell cycle progression and chronic post-
replication repair (PRR) activation, and trigger the DNA damage
response (DDR). The gravity of the phenotype correlates with
the silencing efficiency or the severity of the mutation. Intri-
guingly, recent studies linked DDR to activation of an immune
response, suggesting a possible mechanism for the pathogenesis
of AGS linked to defective RNase H2 functions.
RESULTS
RNase H2 depletion in human cells impairs normal cell
proliferation
Recent in vivo studies in yeast and mouse cells suggest a role for
RNase H2 in the maintenance of genome stability through the
removal from genomic DNA of rNMPs misincorporated
during the replication process (11,12,25). However, the link
between this role of RNase H2 and the pathogenesis of AGS is
unknown.
To better understand the consequences of reduced RNase H2
activities in human cells, we used HeLa cells where the level of
RNase H2 can be modulated by RNA interference. To achieve a
stable down-regulation of RNase H2, we generated a variety of
lentiviral vectors carrying shRNA sequences specifically
designed to interfere with the expression of either the catalytic
A subunit or the structural B subunit, which are connected, re-
spectively, to the most severe phenotype or the most common
mutations found in AGS patients (30). The degree of silencing
was evaluated using quantitative reverse transcriptase-polymerase
chain reaction and/or western blotting using commercial
antibodies or antibodies developed in-house (Supplementary
Material, Fig. S1).
After lentiviral infection, HeLa cells were analyzed for silen-
cing efficiency (Fig. 1A and B). As shown in Figure 1B, western
blot analysis revealed that down-regulation of any RNase H2
subunit affects the expression levels of the other subunits,
likely due to destabilization of the entire heterotrimeric
complex. Upon depletion of RNase H2, proliferation of HeLa
and MRC5VI cells was significantly reduced compared with
control cells (Fig. 1C; Supplementary Material, Fig. S2) and
this effect seems to increase with the efficiency of silencing
(Supplementary Material, Fig. S3). The proliferation defect
can be only partially ascribed to cell death, as revealed by the
modest increase in lactate dehydrogenase (LDH) release
respect to control cells; furthermore, silenced cells did not
exhibit evident Casp3 cleavage, a marker of Casp3-mediated
apoptotic pathway activation (Fig. 1D and E).
These findings suggest that in human cells a decreased level of
RNase H2 affects cell proliferation through mechanisms that
cannot be compensated by RNase H1 activity.
Depletion of RNase H2 causes replication stress and
chronic activation of PRR
Given that RNase H2 silencing had only a limited impact on cell
vitality, we investigated the possibility that loss of RNase H2
function may lead to defective cell cycle progression.
Exponentially growing HeLa cells were labeled with BrdU to
mark replicating cells, and analyzed by cytofluorimetry for total
DNA content and for active replication. RNase H2 silencing
affected cell cycle progression, resulting in a reproducible and
significant accumulation of cells in S and G2-M phases (Fig. 2A).
Cell cycle progression was further analyzed in a kinetic experiment
where cells traversing S-phase were labeled with a pulse of BrdU
andfollowedfor8 hafter release inBrdU-freemedium.Whencom-
pared with the SCRAMBLE control, cells depleted for RNase H2
were delayed in late-S/G2 phase and were very slow in getting
back into G1 phase (Fig. 2B), indicative of replication problems.
Similar results were obtained using MRC5VI cells, indicating that
it is not a cell-specific effect (Supplementary Material, Fig. S4A).
Our previous work in budding yeast demonstrated that, in the
absence of RNase H activity, misincorporated rNMPs challenge
the efficiency of the replication machinery and rnh1D rnh201D
cells can cope with such problem by activating the PRR repair
pathway to bypass the blocking ribonucleotide (25). We
hypothesized that a similar problem may be responsible for the
defects in completing S-phase and for the temporary G2/M
arrest observed in HeLa cells after RNase H2 down-regulation.
To evaluate the involvement of PRR, we analyzed the level of
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ubiquitylated proliferating cell nuclear antigen (PCNA), a bio-
chemical readout of PRR activation, in RNase H2-silenced cells.
Western blotting analysis on protein extracts obtained from
exponentially growing cells, revealed an accumulation of ubi-
quitylated PCNA in cells depleted of RNase H2A or RNase
H2B, indicating that if RNase H2 is not fully functional, cells
use the post-replication repair pathway to complete replication
(31) (Fig. 3A). This hypothesis was strengthened by the observa-
tion that RNase H2-depleted cells are hypersensitive to low
doses of the replication stress-inducing agent hydroxyurea
(HU) (Fig. 3B; Supplementary Material, Fig. S4B). Low levels
of HU decrease the levels of dNTPs pools and are toxic for
cells suffering endogenous replication stress, while they are
well tolerated by cells normally traversing replication phase
(25,32,33) supporting the notion that RNase H2 depletion
impairs normal replication fork progression.
Depletion of RNase H2 triggers the activation of genome
integrity maintenance pathways in human cells
Given the problems in completing chromosomal DNA replica-
tion and the delay in traversing mitosis into the next G1, we ana-
lyzed several markers of activated DDR pathways.
We failed to detect damage-specific phosphorylation of Chk1
and Chk2 checkpoint kinases (Fig. 4A). On the other hand,
RNase H2 silenced cells, analyzed at single cell level by
immunofluorescence, exhibit a clear increase in 53BP1 foci for-
mation (Fig. 4B and C; Supplementary Material, Fig. S5A and
B). 53BP1 is a well-known mediator of DNA DSB repair, and
its accumulation in foci has been recently associated to replica-
tion stress (34–37). Furthermore, depletion of RNase H2A or
RNase H2B leads to the formation of micronuclei (Fig. 4D;
Supplementary Material, Fig. S6), which is indicative of
chromosome breakage and increased genome instability (38).
Taken together, our data reveal that human RNase H2 is
required for the maintenance of genome integrity and suggest
that, in its absence, genome instability may be a consequence
of replication fork stalling.
Cells derived from AGS patients exhibit chronic activation
of PRR DNA damage markers
Seven genes have been found to be involved in AGS (1–4,39),
but over 50% of the AGS patients carry mutations in the three
genes encoding the RNase H2 subunits (3,4,30). The most
frequent mutations found in patients occur in the gene encoding
the structural B subunit, and are often associated to milder phe-
notypes. Conversely, a G37S mutation affecting the catalytic A
subunit is less frequent and it is associated to severe AGS symp-
toms. In any case, all mutations in the three RNase H2 genes
trigger, to a different extent, an increased instability of the
RNase H2 enzymatic complex (2,11,26–28,40).
We wondered whether the effects we have seen in HeLa cells
after down-regulating RNase H2 may have some relationship
with the pathogenesis of AGS. To start approaching this ques-
tion, we characterized in detail EBV-immortalized lymphoblas-
toid cells derived from AGS patients. In particular, we analyzed:
(i) the level of the RNase H2 complex subunits, (ii) the status
Figure1.Low levels of RNase H2 reduce cell proliferation. HeLa cells were silenced usingone shRNA sequence against subunit A and two different sequencesagainst
subunit B (shRNH2A, shRNH2B.1, shRNH2B.2). As control, non-targeting shSCRAMBLE (shSCR) sequence was used. Efficiency of silencing was monitored by
RT-PCR (A) or immunoblotting (B). Silencing of A or B subunits affects protein level of subunit C (B). MTS assay was performed in triplicate to monitor cell pro-
liferation. Cells were plated 7 days after infection and analyzed every 24 h. Mean + s.e.m. (C). Relative LDH release was measured 11 days after infection. Mean +
s.e.m. of triplicate (D). Representative graphs are shown to avoid blending of the data due to variation in timing and efficiency of silencing. All experiments were
performed three times and produced similar results. Immunoblot for Caspase3 was performed on total protein extract 11 days after infection. Protein extract from
HeLa cells treated with H2O2 were used as positive control (E).
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of post-replication repair activation and (iii) the presence of
markers of DDR activation in patient-derived cells, carrying
the G37S mutation in the A subunit or the A177T and the
A177T-T163I hetero-compound mutations in the B subunit.
As shown in Figure 5A, both the mutation in subunit A and the
mutations in subunit B have a destabilizing effect on the RNase
H2 proteins. Indeed, the protein level of each RNase H2 subunit
is noticeably decreased in AGS patients-derived cells, consist-
ently with in vitro thermal stability assays (29). Intriguingly,
the analysis of PCNA revealed clear constitutive mono-
ubiquitylation in G37S-mutant cells, and a low but reproducible
ub-PCNA signal in A177T and A177T-T163I cells (Fig. 5B),
paralleling the severity of the phenotype reported in patients.
Interestingly, phosphorylation of p53 on serine 15, an estab-
lished marker of DNA damage (41), was detected at a compar-
able level in all mutated cells, suggesting that the impairment
of RNase H2 function in patients triggers the DDR (Fig. 5C).
This is further supported by the observation that 53BP1 foci
are increased in all AGS-mutated cells (Fig. 5D; Supplementary
Material, Fig. S7).
Impaired RNase H2 function leads to accumulation
of rNMPs in chromosomal DNA
Given the phenotypes reported above, we hypothesized that
RNase H2-defective cells derived from AGS patients may accu-
mulate rNMPs within chromosomal DNA, similarly to what was
observed in mouse (11,12). To test this hypothesis, we evaluated
the presence of ribonucleotides in genomic DNA preparations
that were digested with bacterial RNaseHII. Nicks generated
by the enzyme were then detected through the incorporation
of radiolabeled dNTPs by DNA polymerase I (12). Genomic
DNA from AGS and control lymphoblastoid cells was extracted
and analyzed as described above. Despite a noticeable back-
ground, likely due to nicks introduced during DNA extraction,
Figure 5E shows that G37S-mutated and A177T-T163I hetero-
compound cells exhibit a strong rNMP-dependent radioactive
signal (compare lanes 5–6 and lanes 7–8), while in A177T
cells we could not detect a clear increase in the signal after treat-
ing genomic DNA with bacterial RNHII. The protocol was
Figure 2.RNase H2 depletion causes a delay in S-G2 phases. Cell cycle distribution of asynchronous HeLa cells. Histograms represent the percentage of cells in G1,
S and G2-M phase. FACS profiles were analyzed using CellQuest software. Data are mean+ s.e.m. of four independent experiments. ∗P , 0.02 (t-test) (A). Repre-
sentative images of a cell kinetic experiment. Asynchronous HeLa cells were pulse labeled with BrdU and released in BrdU-free medium. Cells were harvested and
stained with anti-BrdU and propidium iodide (PI) at indicated time points (hours after release). R1 ¼ early S-phase; R2 ¼ mid-S-phase; R3 ¼ late S/G2 phase (arrows
indicate cells entered in new G1 phase) (B).
Figure 3. Inactivation of RNase H2 induces replication stress. Immunoblot on
total protein extract from control and RNase H2A/B silenced HeLa cells
against PCNA. Vimentin was used as loading control (A). Sensitivity to HU
was evaluated by colony forming assay. Control and silenced HeLa cells were
incubated for 14 days with or without HU 0.1 mM. The histograms report the per-
centage of surviving colonies respect to the untreated sample. Experiments were
performed in duplicate or triplicate. Error bars represent mean + s.e.m. (B).
∗∗P , 0.003 (t-test).
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validated using wild-type (lanes 9–10) or RNase H1 and H2
deleted budding yeast strains (lanes 11–12). These results indi-
cate that in cells derived from AGS patients, RNase H2 muta-
tions affecting the catalytic activity or the stability of the
complex cause the accumulation of rNMPs in genomic DNA
that represent obstacles for replication forks progression,
leading to fork stalling and genome instability.
DISCUSSION
AGS, a rare genetic autoimmune disorder (30), is caused by
defects in nucleic acids metabolic enzymes. Over 50% of
the patients carry mutations affecting RNase H2, the main
enzyme involved in the processing of single rNMPs embedded
in the eukaryotic chromosomes (7,42).
Ribonucleotides recently emerged as the main non-canonical
nucleotides present in genomic DNA (14,16); indeed, they are
incorporated into DNA by replicative polymerases with surpris-
ingly high frequency (1rNMP/1000dNMP) (10). Moreover, it
is possible that imperfect processing of Okazaki fragments con-
tribute to increase the load of genomic rNMPs. Although the pres-
ence of rNMPswithinchromosomal DNA has been shown tohave
relevant physiological functions, acting as imprint signals and
directing the mismatch repair machinery to correct the newly
synthesized DNA strand (43–45), rNMPs accumulation in the
genome has deleterious consequences, leading to mutagenesis
and replication stress (11,12,16,25). Despite the increased interest
in this research area, a mechanistic connection between RNase H2
functions and AGS pathogenesis is still missing.
Knock-in mice carrying the most common AGS mutation in
RNase H2 do not display any obvious phenotype, possibly due
to differences in the pathways between humans and mice (11).
On the other hand, RNase H2 knock-out mice or mice with
almost completely abolished RNase H2 activity die early
during embryogenesis or perinatally (11,12). Thus, additional
cellular mammalian models are necessary to gain insights on
the molecular mechanisms linking RNase H2 defects to AGS
pathogenesis.
To overcome the drastic effects caused by total loss of RNase
H2 activity and differences linked to the employment of murine
models, we used human cells where RNase H2 expression was
modulated by RNA interference. We found that, shortly after in-
fectionwith lentiviralvectorscarryingspecific shRNA sequences,
HeLa RNase H2-silenced cells showed cell cycle defects leading
to accumulation of cells in S and G2/M phases. Such defects are
not cell line specific since we obtained similar results with
MRC5VI cell lines. Moreover, the cell cycle progression
defects correlate with the activation of the PRR pathways and
increasedsensitivity to replicationstress-inducingagents, similar-
ly to what we previously observed in budding yeast (25). When
RNase H2 activity is defective, chromosomes accumulate
rNMPs that, when embedded in the template DNA strand,
create an obstacle to replication fork progression. In this situation,
cells need PRR activity to complete chromosomal DNA replica-
tion, as suggested by the chronic ubiquitylation of PCNA.
These findings prompted us to ask whether human cells
obtained from AGS patients were also defective in ribonucleo-
tide excision repair, were affected in normal DNA replication
and were exhibiting a chronically active PRR pathway, neces-
sary for completing chromosomal DNA replication in the pres-
ence of genomic rNMPs. We thus obtained lymphoblastoid
cells carrying mutations in either the A or the B subunits of the
RNase H2 enzyme. The AGS mutations we tested reduced the
stability of the RNase H2 complex, in most cases leading to a
detectable accumulation of unrepaired rNMPs within genomic
Figure4.Depletion of RNase H2 induces DDR and causes genome instability. Total protein extract of silenced HeLa cells was blotted with indicated antibodies, HeLa
irradiated with UV (20 J/m2) were used as control (pChk1, anti-Chk1 Ser317; L, low exposure; H, high exposure) (A). HeLa cells were immunostained with an
anti-53BP1 antibody and DAPI to stain nuclear DNA (scale bar: 10 mm, magnification ×63) (B). The histograms indicate the percentage of cells that have at
least five 53BP1 foci/nucleus. Error bars represent mean + s.e.m.; n ¼ 4 for shRNH2A and shRNH2B.1, n ¼ 5 for shRNH2B.2; ∗P , 0.05, ∗∗P , 0.01 (t-test).
(C) The histograms in (D) indicate the percentage of micronucleated cells. Error bars represent mean + s.e.m.; n ¼ 4; ∗P , 0.02 (t-test).
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DNA. We report, indeed, that AGS2 and AGS4 cells accumulate
high levels of rNMPs that remain embedded in genomic DNA
and exhibit constitutive ubiquitylation of PCNA, indicative of
an active post-replication repair process linked to increased
replication stress. Interestingly, cells carrying the RNase
H2A-G37S mutation, exhibit a stronger accumulation of mono-
ubiquitylated PCNA, correlating the level of PCNA modifica-
tion to the severity of the mutation.
The low sensitivity of the assays represents a limit for the ana-
lysis of milder mutations. For this purpose, it will be necessary to
Figure 5.Patients-derived AGS cells accumulate genomic rNMPs and replication stress markers. Protein levels of the three subunits of RNase H2 complex from cells
derived from healthy donor and AGS patients are compared by western blot (top panel) and quantified (bottom panel). Error bars represent mean + s.e.m., n ¼ 3 (A).
Immunoblot against PCNA on total protein extract from healthy donor and AGS-derived lymphoblastoid cells, MRC5VI cells UV irradiated (20 J/m2) were used as
positive control for PCNA ubiquitylation (L, low exposure; H, high exposure) and Vinculin as loading control (top panel). The ratio of monoubiquitinated PCNA to
total PCNA is plotted (bottom panel). Error bars represent mean + s.e.m., n ¼ 5 for healthy donor, A177T, A177T-T163I; n ¼ 2 for G37S (B). DDR in control and
AGS-mutated cells was monitored by western blot analysis using anti-P-Ser-15-p53 antibody and Actin as loading control (top panel). The ratio between P-Ser-15-p53
and total p53 was quantified (bottom panel). Error bars represent mean + s.e.m., n ¼ 3 (C). Representative images of immunostaining anti-53BP1 and nuclei (scale
bar: 10 mm,magnification×63) (toppanel). Quantification of 53BP1foci formation in lymphoblastoid cells fromhealthy donor and AGSpatients.Error bars represent
mean + s.e.m., n ¼ 5 for A177T and A177T-T163I, n ¼ 8 for G37S (bottom panel). ∗P , 0.02; ∗∗∗P , 0.0001(t-test) (D). DNA extracted from control and AGS-
mutated cells was digested (even lanes) with bacterial RNase HII before nick translation reaction in the presence of 32P-dCTP. Labeled DNA was run on a 1% agarose
gel and visualized by autoradiography. Control samples were not digested with RNase HII (odd lanes) to detect background signal; wild-type or RNase H1 and H2
deleted (rnh1Drnh201D) buddingyeast strainswere used to validate the protocol (lanes9–12) (top panel). Graph represents quantification of three independent experi-
ments, as described in Materials and Methods (bottom panel). Error bars represent mean + s.e.m., n ¼ 3 (E).
6 Human Molecular Genetics, 2014
 at Edinburgh U
niversity on N
ovem
ber 28, 2014
http://hm
g.oxfordjournals.org/
D
ow
nloaded from
 
improve the assay itself and/or perform further analyses under
different stress conditions. Indeed, the AGS phenotype may
remain quiescent for a long time and the pathological conditions
may arise only after some still unknown stress stimuli (30).
Overall, we report that RNase H2 silencing in human cell lines
or RNase H2 mutations in AGS patients-derived cell lines
increased genome instability and activate DDR markers, likely
as consequence of replication stress, in agreement with some
observations in mouse cells (11,12). We also observed that
RNase H2 silencing affect the whole complex stability in agree-
ment with what recently reported in vivo (46). In fact, in a study
of the spatiotemporal dynamics of the whole complex, it was
found that AGS-associated mutations alter complex formation,
efficiency of recruitment and exchange kinetics at sites of DNA
replication and laser-induced DNA damage. Interestingly, this
study showed that RNase H2 recruitment to DNA depends upon
its catalytic activity but is also aided by its interaction with PCNA.
Our data indicate that PCNA ubiquitylation is directly linked
to defects in RNase H2 as seen in AGS patients, suggesting that
such PCNA modification is relevant to tolerate unrepaired
genomic rNMPs, consistently with what observed in the yeast
model system (25).
Altogether, we hypothesize that the DDR per se may, at least
partially, account for the clinical symptoms related to RNase H2
mutations in AGS patients, in agreement with growing evidence
linking the DDR to the innate immune response. Activation of
the DDR was reported to induce cell surface expression of
ligands for NKG2D, the stimulatory receptor expressed by
natural killer and by T-cell sub-populations, and more recent
data showed that IFN is produced in response to DNA damage
(47–49). It is likely that other molecular pathways are also
linked to RNase H2-dependent AGS pathogenesis. Among
them a possible role of RNase H2 in retroelement metabolism
must be considered. Indeed, the TREX1 and SAMHD1 genes
which are mutated in a subset of AGS patients (2,3) are involved
in HIV infection and/or endogenous retroelements metabolism
(50–54). Moreover, RNase H2 was identified in a high-
throughput screening as a factor that facilitate HIV replication
likely by removing ribonucleotides incorporated by errors of
HIV reverse transcriptase (21,55).
In summary, we provide evidence that the reduction in RNase
H2 activity found in cells from AGS patients is responsible for
the accumulation of rNMPs in genomic DNA, thus inducing rep-
lication stress that, in turn, promotes genome instability and trig-
gers the DDR. Although other pathways likely account for the
AGS symptoms, it is possible that the increase in IFN levels, a
signature of the AGS disorder, is induced by the DDR itself. If
this were the case it would be interesting to see whether DDR
inhibition would reduce IFN level and attenuate the autoimmune
response.
MATERIALS AND METHODS
Antibodies and chemicals
The following antibodies were used: anti-RNase H2C (Protein-
Tech, 1 : 1000), anti-RNase H2A (Abcam, 1 : 1000), anti-Actin
(Santa Cruz Biotechnology, 1 : 10 000); anti-RNase H2B (pro-
duced in this work, 1 : 500); anti-Caspase3 (Cell Signaling, 1 :
1000); anti-PCNA (PC-10, 1 : 200) was kindly provided by
S. Sabbioneda; anti-BrdU FITC-conjugated (BD Biosciences,
1 : 50), anti-Chk1 (Cell Signaling, 1 : 200); anti-Chk2 (Cell Sig-
naling, 1 : 1000); anti-P-Chk1-Ser317 (Cell Signaling, 1 : 1000);
anti-P-Chk2-Thr68 (Cell Signaling, 1 : 500); anti p53 (DO1,
GeneSpin, 1 : 1000); anti-P-p53-Ser15 (Cell Signaling, 1 :
1000); anti-53BP1 (Cell Signaling, 1 : 150 for immunofluores-
cence; 1 : 1000 for western blot); anti-Vinculin (Sigma, 1 : 40
000); anti-Vimentin (Cell Signaling, 1:10 000); anti-Tubulin
(Sigma, 1 : 1000). Secondary antibodies were goat anti-mouse
or goat anti-rabbit conjugated to HRP (western blot) or to
Alexa Fluor 488 or Alexa Fluor 594 (immunofluorescence).
Hydroxyurea was used at a final concentration of 0.1 mM. Puro-
mycin was used to a final concentration of 1 mM.
Cell culture
HeLa, MRC5VI and HEK293T cells were cultured in DMEM
containing 10% FBS, penicillin, streptomycin and L-glutamine
and kept at 378C in a humidified atmosphere with 5% CO2.
EBV-immortalized lymphoblastoid cells derived from patients
and control cells were cultured in RPMI containing 20% FBS,
penicillin, streptomycin and L-glutamine and kept at 378C in a
humidified atmosphere with 5% CO2.
Lentiviral vectors production
shRNA sequences targeting subunits A or B of human RNase H2
were cloned using EcoRI and AgeI in pLKO.1-TCR cloning
vector (Addgene). As control SCRAMBLE shRNA cloned in
pLKO.1 vectors was used (Addgene). Lentiviral vectors were
produced by transient co-transfection of pLKO and packaging
plasmids psPAX2 (Addgene) and pMD2.G (Addgene) into
HEK293T. Virus was harvested at 48 posttransfection and infec-
tions were carried out in the presence of 10 mg/ml of polyb-
rene. Following transduction, cells were selected with 1 mg/ml
puromycin.
shRNA sequences
Sense sequences used to silence RNase H2A or RNase H2B are:
RNase H2A: 5′-GAAATGGCAGTTCGTGGAGAA-3′, RNase
H2B.1: 5′-GCTTCTCCACTACCTCATAAA-3′, and RNase
H2B.2: 5′-ATCAAACTGTGGCAGCATTAA-3′.
Western blotting
Cells were lysed in 1% sodium dodecyl sulfate (SDS) sample
buffer (62.5 mM Tris–HCl, pH 6.8, 2% SDS, 10% glycerol,
50 mM DTT, 0.01% bromophenol blue), sonicated 10 s and
heated at 958C for 5 min; equal amounts of total protein extracts
were analyzed by SDS–polyacrylamide gel electrophoresis.
Protein markers from New England Biolabs, Fermentas or
GeneSpin were used.
Total RNA extraction and retrotranscription
Total RNA was isolated using High Pure RNA isolation kit
(Roche) and 0.5–1 mg of RNA was retrotranscribed using
M-MLV Reverse Transcriptase (RNaseH-) (Euroclone) accord-
ing to manufacturer’s protocol.
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Primer sequences
RNase H2A for: 5′-GGATACTGATTATGGCTCAGGCTA
CC-3′; RNase H2A rev: 5′-ATGTGATCTTCCTGAGTCCC
TCCT-3′; RNase H2B for: 5′-GCATCTTGTTGCTGAAACTT
CCTGG-3′; RNase H2B rev: 5′-TCCTTGTCAGTGGAAGCTT
GGTCA-3′; GAPDH for: 5′-AAGGTCGGAGTCAACGGA
TTTGGT-3′; GAPDH rev: 5′-GCTCCTGGAAGATGGTGA
TGGGATTT-3′.
Proliferation and cytotoxicity assays
HeLa cells were seeded in 96-well plates at a density of 3000–
5000 cells per well. Viable cells were assessed by MTS assay
every 24 h for 4 days at 490 nm. Leakage of LDH was measured
as an index of lethal membrane injury (necrosis) using a com-
mercial kit (Promega).
Cell cycle and fluorescence-activated cell sorting analysis
Exponentially growing cells were pulse labelled with 100 mM
BrdU for 30 min and released in BrdU-free medium for different
time points, or immediately harvested by trypsinization and
washed in phosphate buffered saline (PBS), fixed in 70% ice
cold ethanol and either stained for anti-BrdU (AlexaFluor 488
as secondary antibody) and propidium iodide to quantitate repli-
cating cells. Fluorescence-activated cell sorting (FACS) ana-
lysis was performed on a BD FACScan; quantification used
Cell Quest software (BD Bioscience).
Colony forming assay
One hundred HeLa cells were plated in p60 dishes in duplicate
and allowed to grow for 14 days in complete medium in the pres-
ence of 0.1 mM HU or left untreated. After 14 days, cells were
fixed in methanol and stained with crystal violet 1%. Colonies
of .70 cells were scored under microscope.
Immunofluorescence
Cells were plated on glass slides, washed twice in PBS and pre-
extracted for 5 min at 48C in CSK buffer (0.1% Triton X-100
10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM sucrose, 3 mM
MgCl2, 1 mM EGTA and 1 mM EDTA). Lymphoblastoid cells
were cytospun to polysine slides (Thermo Scientific) for 4 min
at room temperature, 800 rcf. Cells were then fixed in PFA 4%
for 15 min at RT and washed twice in PBS. Cells were permea-
bilized in PBS/0, 5% Triton X-100 for 5 min at 48C and blocked
in PBS/10% BSA for 1 h at RT. Anti-53BP1 antibody was
diluted 1 : 100 in PBS/0.1% Tween and incubated for 3 h at
RT. Secondary antibody was diluted 1 : 1000 in PBS/0, 1%
Tween and incubated for 1 h at RT. Cells were rinsed in PBST
0.1 three times for 10 min and mounted using ProLong Gold
(Invitrogen) containing DAPI to stain nuclei. Images were
obtained using a Leica DMRA2 Microscope (with Leica
FW4000 software) with a ×63 oil immersion objective.
Foci and micronuclei counting
Cells with more than five 53BP1 foci per nucleus were counted
covering randomly whole coverslip. At least 200 nuclei were
scored for each sample. For micronuclei at least 500 cells per
sample were counted.
Western blot quantification
Western blot was quantified using ImageJ software. The ratio
between modified protein and total protein was normalized on
loading control and expressed as fold change respect to control
sample.
Ribonucleotides incorporation assay
Genomic DNA was purified using Qiagen Genomic-Tip and
Qiagen Genomic DNA buffer set and was digested with 0.5 U
Escherichia coli RNase HII (New England Biolabs) in 50 ml at
378C for 2.5 h. After precipitation in 0.3 M sodium acetate, pH
7, and ethanol, DNA was resuspended in TE 0, 1%. Nick trans-
lation was performed using 5 U of E. coli DNA polymerase I
(New England Biolabs), 20 mM of unlabeled dA/-T/-GTP, and
5 mC a32PdCTP in a final volume of 20 ml. The reaction was
incubated at 168C for 30 min. Labeled DNA was separated
from unincorporated nucleotides by electrophoresis on a 1%
TAE agarose gel. After drying, the radioactive gel was analyzed
using a Typhoon. The relevant 32P-signal of each sample was
normalized on total genomic DNA measured by ethidium
bromide staining. The ratio between E. coli RNHII-treated and
untreated sample was expressed as fold change respect to the
control sample.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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